3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1358.5

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 3020-OL.HK.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-10 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1318:HK Mao Geping Cosmetics Co Ltd

+2.10 (+3.61%)

USD 26.31B
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

N/A

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

+0.07 (+12.96%)

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0332-OL:HK YUANHENG GAS

N/A

N/A
0243-OL:HK QPL INT'L

N/A

N/A
0408-OL:HK YIP'S CHEMICAL

+0.01 (+0.70%)

N/A
0259-OL:HK YEEBO (INT'L H)

+0.07 (+2.21%)

N/A
0419-OL:HK JIUHAO HEALTH

N/A

N/A

ETFs Containing 3020-OL:HK

IHF iShares U.S. Healthcare P.. 10.46 % 0.43 %

-0.54 (0.00%)

N/A
TETF 6.19 % 0.64 %

N/A

N/A
MID American Century Mid Cap .. 5.64 % 0.00 %

-0.80 (0.00%)

USD 0.08B
BGU:CA Bristol Gate Concentrated.. 5.13 % 0.85 %

-0.92 (0.00%)

CAD 0.12B
BGU-U:CA Bristol Gate Concentrated.. 5.13 % 0.00 %

-0.01 (0.00%)

CAD 0.11B
FHI:CA CI Health Care Giants Cov.. 4.97 % 0.75 %

-0.04 (0.00%)

CAD 0.08B
FHI-B:CA CI Health Care Giants Cov.. 4.97 % 0.00 %

N/A

CAD 0.05B
IAI iShares U.S. Broker-Deale.. 4.40 % 0.42 %

-3.96 (0.00%)

N/A
LCG Sterling Capital Focus Eq.. 4.29 % 0.00 %

-0.50 (0.00%)

USD 0.04B
PSL Invesco DWA Consumer Stap.. 3.10 % 0.60 %

-1.62 (0.00%)

USD 0.09B
HDIV 2.83 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 2.04 % 0.00 %

N/A

CAD 0.09B
RYH 1.72 % 0.40 %

N/A

N/A
DSTL Distillate US Fundamental.. 1.60 % 0.00 %

-0.79 (0.00%)

USD 2.03B
IS07:F iShares IV Public Limited.. 1.30 % 0.00 %

-0.04 (0.00%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 1.30 % 0.00 %

-0.09 (0.00%)

USD 0.01B
HONR 1.20 % 0.65 %

N/A

N/A
FSWD:LSE iShares Edge MSCI World M.. 1.12 % 0.00 %

-1.88 (0.00%)

N/A
IFSW:LSE iShares Edge MSCI World M.. 1.12 % 0.00 %

-0.17 (0.00%)

N/A
IBCZ:F iShares IV Public Limited.. 1.12 % 0.00 %

+0.01 (+0.00%)

N/A
IBCZ:XETRA iShares Edge MSCI World M.. 1.12 % 0.00 %

-0.05 (0.00%)

USD 0.40B
VVL:CA Vanguard Global Value Fac.. 0.63 % 0.40 %

-0.44 (0.00%)

N/A
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.15 (+0.00%)

USD 0.05B
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

N/A
DRFU:CA Desjardins RI USA Multifa.. 0.00 % 0.57 %

-0.34 (0.00%)

CAD 5.97M
SPVM Invesco S&P 500 Value wit.. 0.00 % 0.39 %

-1.00 (0.00%)

USD 0.09B
RYF 0.00 % 0.40 %

N/A

N/A
WBIF WBI BullBear Value 3000 E.. 0.00 % 1.05 %

-0.42 (0.00%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

-1.69 (0.00%)

N/A
DBPD:F Xtrackers - ShortDAX x2 D.. 0.00 % 0.00 %

N/A

N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

-1.24 (0.00%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.04% 79% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.04% 79% B- 76% C+
Trailing 12 Months  
Capital Gain 24.58% 82% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.58% 79% B- 78% C+
Trailing 5 Years  
Capital Gain 97.03% 82% B 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 97.03% 82% B 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 17.25% 77% C+ 77% C+
Dividend Return 17.25% 75% C 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 20.13% 74% C 91% A-
Risk Adjusted Return 85.66% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike